Severe genitourinary toxicity following radiation therapy for prostate cancer - How long does it last?

Sung Kim, Dirk F. Moore, Weichung Shih, Yong Lin, Hui Li, Yu Hsuan Shao, Shunhua Shen, Grace L. Lu-Yao

研究成果: 雜誌貢獻文章

20 引文 (Scopus)

摘要

Purpose: Radiation therapy is a common treatment for localized prostate cancer but long-term data are sparse on treatment related toxicity compared to observation. We evaluated the time course of grade 2-4 genitourinary toxicities in men treated with primary radiation or observation for T1-T2 prostate cancer. Materials and Methods: We performed a population based cohort study using Medicare claims data linked to SEER (Surveillance, Epidemiology and End Results) data. Cumulative incidence functions for time to first genitourinary event were calculated based on the competing risks model with death before any genitourinary event as a competing event. The generalized estimating equation method was used to evaluate the risk ratios of recurrent events. Results: Of the study patients 60,134 received radiation therapy and 25,904 underwent observation. The adjusted risk ratio for genitourinary toxicity was 2.49 (95% CI 2.00-3.11) for 10 years and thereafter. Patients who had required prior procedures for obstruction/stricture, including transurethral prostate resection, before radiation therapy were at significantly increased risk for genitourinary toxicity (risk ratio 2.78, 95% CI 2.56-2.94). Conclusions: This study demonstrates that the increased risk of grade 2-4 genitourinary toxicities attributable to radiation therapy persists 10 years after treatment and thereafter. Patients who required prior procedures for obstruction/stricture were at higher risk for genitourinary toxicity than those without these preexisting conditions.
原文英語
頁(從 - 到)116-121
頁數6
期刊Journal of Urology
189
發行號1
DOIs
出版狀態已發佈 - 一月 2013
對外發佈Yes

指紋

Prostatic Neoplasms
Radiotherapy
Odds Ratio
Observation
Pathologic Constriction
Transurethral Resection of Prostate
Preexisting Condition Coverage
Medicare
Epidemiology
Cohort Studies
Therapeutics
Radiation
Incidence
Population

ASJC Scopus subject areas

  • Urology

引用此文

Severe genitourinary toxicity following radiation therapy for prostate cancer - How long does it last? / Kim, Sung; Moore, Dirk F.; Shih, Weichung; Lin, Yong; Li, Hui; Shao, Yu Hsuan; Shen, Shunhua; Lu-Yao, Grace L.

於: Journal of Urology, 卷 189, 編號 1, 01.2013, p. 116-121.

研究成果: 雜誌貢獻文章

Kim, Sung ; Moore, Dirk F. ; Shih, Weichung ; Lin, Yong ; Li, Hui ; Shao, Yu Hsuan ; Shen, Shunhua ; Lu-Yao, Grace L. / Severe genitourinary toxicity following radiation therapy for prostate cancer - How long does it last?. 於: Journal of Urology. 2013 ; 卷 189, 編號 1. 頁 116-121.
@article{53826ed9fc8449279882913ff0e34c48,
title = "Severe genitourinary toxicity following radiation therapy for prostate cancer - How long does it last?",
abstract = "Purpose: Radiation therapy is a common treatment for localized prostate cancer but long-term data are sparse on treatment related toxicity compared to observation. We evaluated the time course of grade 2-4 genitourinary toxicities in men treated with primary radiation or observation for T1-T2 prostate cancer. Materials and Methods: We performed a population based cohort study using Medicare claims data linked to SEER (Surveillance, Epidemiology and End Results) data. Cumulative incidence functions for time to first genitourinary event were calculated based on the competing risks model with death before any genitourinary event as a competing event. The generalized estimating equation method was used to evaluate the risk ratios of recurrent events. Results: Of the study patients 60,134 received radiation therapy and 25,904 underwent observation. The adjusted risk ratio for genitourinary toxicity was 2.49 (95{\%} CI 2.00-3.11) for 10 years and thereafter. Patients who had required prior procedures for obstruction/stricture, including transurethral prostate resection, before radiation therapy were at significantly increased risk for genitourinary toxicity (risk ratio 2.78, 95{\%} CI 2.56-2.94). Conclusions: This study demonstrates that the increased risk of grade 2-4 genitourinary toxicities attributable to radiation therapy persists 10 years after treatment and thereafter. Patients who required prior procedures for obstruction/stricture were at higher risk for genitourinary toxicity than those without these preexisting conditions.",
keywords = "prostate, prostatic neoplasms, radiotherapy, SEER program, toxicity",
author = "Sung Kim and Moore, {Dirk F.} and Weichung Shih and Yong Lin and Hui Li and Shao, {Yu Hsuan} and Shunhua Shen and Lu-Yao, {Grace L.}",
year = "2013",
month = "1",
doi = "10.1016/j.juro.2012.08.091",
language = "English",
volume = "189",
pages = "116--121",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Severe genitourinary toxicity following radiation therapy for prostate cancer - How long does it last?

AU - Kim, Sung

AU - Moore, Dirk F.

AU - Shih, Weichung

AU - Lin, Yong

AU - Li, Hui

AU - Shao, Yu Hsuan

AU - Shen, Shunhua

AU - Lu-Yao, Grace L.

PY - 2013/1

Y1 - 2013/1

N2 - Purpose: Radiation therapy is a common treatment for localized prostate cancer but long-term data are sparse on treatment related toxicity compared to observation. We evaluated the time course of grade 2-4 genitourinary toxicities in men treated with primary radiation or observation for T1-T2 prostate cancer. Materials and Methods: We performed a population based cohort study using Medicare claims data linked to SEER (Surveillance, Epidemiology and End Results) data. Cumulative incidence functions for time to first genitourinary event were calculated based on the competing risks model with death before any genitourinary event as a competing event. The generalized estimating equation method was used to evaluate the risk ratios of recurrent events. Results: Of the study patients 60,134 received radiation therapy and 25,904 underwent observation. The adjusted risk ratio for genitourinary toxicity was 2.49 (95% CI 2.00-3.11) for 10 years and thereafter. Patients who had required prior procedures for obstruction/stricture, including transurethral prostate resection, before radiation therapy were at significantly increased risk for genitourinary toxicity (risk ratio 2.78, 95% CI 2.56-2.94). Conclusions: This study demonstrates that the increased risk of grade 2-4 genitourinary toxicities attributable to radiation therapy persists 10 years after treatment and thereafter. Patients who required prior procedures for obstruction/stricture were at higher risk for genitourinary toxicity than those without these preexisting conditions.

AB - Purpose: Radiation therapy is a common treatment for localized prostate cancer but long-term data are sparse on treatment related toxicity compared to observation. We evaluated the time course of grade 2-4 genitourinary toxicities in men treated with primary radiation or observation for T1-T2 prostate cancer. Materials and Methods: We performed a population based cohort study using Medicare claims data linked to SEER (Surveillance, Epidemiology and End Results) data. Cumulative incidence functions for time to first genitourinary event were calculated based on the competing risks model with death before any genitourinary event as a competing event. The generalized estimating equation method was used to evaluate the risk ratios of recurrent events. Results: Of the study patients 60,134 received radiation therapy and 25,904 underwent observation. The adjusted risk ratio for genitourinary toxicity was 2.49 (95% CI 2.00-3.11) for 10 years and thereafter. Patients who had required prior procedures for obstruction/stricture, including transurethral prostate resection, before radiation therapy were at significantly increased risk for genitourinary toxicity (risk ratio 2.78, 95% CI 2.56-2.94). Conclusions: This study demonstrates that the increased risk of grade 2-4 genitourinary toxicities attributable to radiation therapy persists 10 years after treatment and thereafter. Patients who required prior procedures for obstruction/stricture were at higher risk for genitourinary toxicity than those without these preexisting conditions.

KW - prostate

KW - prostatic neoplasms

KW - radiotherapy

KW - SEER program

KW - toxicity

UR - http://www.scopus.com/inward/record.url?scp=84870949940&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870949940&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2012.08.091

DO - 10.1016/j.juro.2012.08.091

M3 - Article

C2 - 23164376

AN - SCOPUS:84870949940

VL - 189

SP - 116

EP - 121

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 1

ER -